Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1095-1099

  Hui, E ^a   Bravis, V ^a,b   Salih, S ^c   Hassanein, M ^d   Devendra, D ^a,b,c  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NHS Brent   (United Kingdom)

^d GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIET RESTRICTION; EVENING DOSAGE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; WEIGHT CHANGE;

AGED; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; ISLAM; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 77953840767     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02347.x     Document Type: Article

References (16)

1. Rashed AH. The fast of Ramadan. BMJ 1992 304 : 521 522.
2. Al-Arouj M, Bouguerra R, Buse J et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 2005 28 : 2305 2311.
3. Salti I, Benard E, Detournay B et al. Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004 27 : 2306 2311.
4. Bouquerra R, Jabrane J, Maatki C et al. Ramadan fasting in type 2 diabetes mellitus. Ann Endocrinol (Paris) 2006 67 : 54 9.
5. Sari R, Balci MK, Akbas SH et al. The effects of diet, sulfonylurea and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004 30 : 169 177.
6. Glimepiride in Ramadan (GLIRA) study group. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care 2005 28 : 421 422.
7. Hassanein M, Bravis V, Hui E et al. Ramadan-focused education and awareness in type 2 diabetes. Diabetologia 2009 52 : 367 368.
8. Uysal A, Erdogan MF, Sahin G et al. Clinical and metabolic effects of fasting in 41 type 2 patients during Ramadan. Diabetes Care 1998 21 : 2033 2034.
9. Cesur M, Corapcioglu D, Gursoy A et al. A comparison of glycaemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract 2007 75 : 141 147.
10. Bakiner O, Ertorer ME, Bozkirli E et al. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetologia 2009 46 : 63 5.
11. Gharbi M, Akrout M, Zouai B. Contribution des prises alimentaires pendant et en dehors du Ramadan. East Mediterr Health J 2003 9 : 131 140.
12. Benaji B, Mounib N, Roky R et al. Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 2006 73 : 117 125.
13. Garber AJ, Ligthelm R, Christiansen JSD et al. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab 2007 9 : 630 639.
14. Kobeissy A, Zantout MS, Azar ST. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Clin Ther 2008 30 : 1408 1415.
15. Mattoo V, Milicevic Z, Malone JK et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Ramadan Study Group. Diabetes Res Clin Pract 2003 59 : 137 143.
16. Bravis V, Hui E, Salih S et al. European implications of the READ (Ramadan focused Education and Awareness in Diabetes) programme [Abstract]. Diabetologia 2008 51 (Suppl. S454.